Literature DB >> 17170887

Timing treatment of a giant intracranial aneurysm by the use of magnetic resonance imaging for the determination of intraluminal clot stability.

C A Jungreis, P J Jannetta, H Yonas.   

Abstract

A 44-year-old man presented with a giant intracranial carotid artery aneurysm. Magnetic resonance (MR) images demonstrated a large amount of fresh intraluminal thrombus in the aneurysm. During test occlusion of the internal carotid artery using an endovascular balloon positioned in the cervical portion of the internal carotid, the patient sustained an apparent embolic episode. The patient was followed for several weeks with serial MR imaging until the thrombus had lysed. Repeat test occlusion followed by permanent carotid occlusion was uneventful. Serial MR evaluations of intraluminal thrombus in large aneurysms might help to determine an optimal time for institution of intervention.

Entities:  

Year:  1993        PMID: 17170887      PMCID: PMC1656406          DOI: 10.1055/s-2008-1060562

Source DB:  PubMed          Journal:  Skull Base Surg        ISSN: 1052-1453


  12 in total

1.  Treatment of intracranial aneurysms with preservation of the parent vessel: results of percutaneous balloon embolization in 84 patients.

Authors:  R T Higashida; V V Halbach; S L Barnwell; C Dowd; B Dormandy; J Bell; G B Hieshima
Journal:  AJNR Am J Neuroradiol       Date:  1990 Jul-Aug       Impact factor: 3.825

2.  Intracavernous aneurysms: treatment by proximal balloon occlusion of the internal carotid artery.

Authors:  J Raymond; J Théron
Journal:  AJNR Am J Neuroradiol       Date:  1986 Nov-Dec       Impact factor: 3.825

3.  The role of ferritin and hemosiderin in the MR appearance of cerebral hemorrhage: a histopathologic biochemical study in rats.

Authors:  K R Thulborn; A G Sorensen; N W Kowall; A McKee; A Lai; R C McKinstry; J Moore; B R Rosen; T J Brady
Journal:  AJNR Am J Neuroradiol       Date:  1990 Mar-Apr       Impact factor: 3.825

4.  Use of detachable balloons for proximal artery occlusion in the treatment of unclippable cerebral aneurysms.

Authors:  A J Fox; F Viñuela; D M Pelz; S J Peerless; G G Ferguson; C G Drake; G Debrun
Journal:  J Neurosurg       Date:  1987-01       Impact factor: 5.115

5.  Aneurysms of the intracavernous carotid artery: natural history and indications for treatment.

Authors:  M E Linskey; L N Sekhar; W L Hirsch; H Yonas; J A Horton
Journal:  Neurosurgery       Date:  1990-06       Impact factor: 4.654

6.  A new method to predict safe resection of the internal carotid artery.

Authors:  E J de Vries; L N Sekhar; J A Horton; D E Eibling; I P Janecka; V L Schramm; H Yonas
Journal:  Laryngoscope       Date:  1990-01       Impact factor: 3.325

7.  Clinical observations on the effect of carotid artery occlusion on cerebral blood flow mapped by xenon computed tomography and its correlation with carotid artery back pressure.

Authors:  D L Steed; M W Webster; E J DeVries; C A Jungreis; J A Horton; L Sehkar; H Yonas
Journal:  J Vasc Surg       Date:  1990-01       Impact factor: 4.268

8.  Aneurysms of the intracavernous carotid artery: clinical presentation, radiographic features, and pathogenesis.

Authors:  M E Linskey; L N Sekhar; W Hirsch; H Yonas; J A Horton
Journal:  Neurosurgery       Date:  1990-01       Impact factor: 4.654

9.  Balloon test occlusion of the internal carotid artery with stable xenon/CT cerebral blood flow imaging.

Authors:  S M Erba; J A Horton; R E Latchaw; H Yonas; L Sekhar; V Schramm; S Pentheny
Journal:  AJNR Am J Neuroradiol       Date:  1988 May-Jun       Impact factor: 3.825

10.  Giant unclippable aneurysms: treatment with detachable balloons.

Authors:  G Debrun; A Fox; C Drake; S Peerless; J Girvin; G Ferguson
Journal:  AJNR Am J Neuroradiol       Date:  1981 Mar-Apr       Impact factor: 3.825

View more
  1 in total

1.  Magnetic Resonance Imaging in Aneurysmal Subarachnoid Hemorrhage: Current Evidence and Future Directions.

Authors:  Sarah E Nelson; Haris I Sair; Robert D Stevens
Journal:  Neurocrit Care       Date:  2018-10       Impact factor: 3.210

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.